Home › Funds › PenderFund Capital Management Ltd. › CDLX
PenderFund Capital Management Ltd. position in CDLX
CARDLYTICS INC · Information Technology
PenderFund Capital Management Ltd. reported holding 53,802,000 shares of CDLX (CARDLYTICS INC) in its Q2 2026 13F filing — a position valued at US$15.5M, representing 2.58% of its reported portfolio and ranking #10 among its reported holdings. PenderFund Capital Management Ltd. has disclosed CDLX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PenderFund Capital Management Ltd.'s CDLX position evolved
PenderFund Capital Management Ltd. first disclosed a stake in CDLX in Q1 2024 at 2,000,000 shares (US$2.5M). The position peaked in Q4 2025 at 47,710,000 shares, worth US$19.4M. Across 10 filings, PenderFund Capital Management Ltd. increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 53,802,000 shares valued at US$15.5M — an increase of 6,092,000 shares quarter over quarter.. Notable position changes include a 125% increase in Q2 2024 (shares fell 61% over the following quarter), a 100% increase in Q4 2024 (shares fell 51% over the following quarter), a 511% increase in Q3 2025 (shares fell 53% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.00M | $2.50M | New |
| Q2 2024 | 4.50M | $5.74M | Add |
| Q3 2024 | 4.50M | $5.60M | Hold |
| Q4 2024 | 9.02M | $11.74M | Add |
| Q1 2025 | 10.02M | $254.50K | Add |
| Q2 2025 | 4.52M | $4.40M | Reduce |
| Q3 2025 | 27.61M | $14.68M | Add |
| Q4 2025 | 47.71M | $19.36M | Add |
| Q1 2026 | 47.71M | $13.52M | Hold |
| Q2 2026 | 53.80M | $15.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CDLX and 13F data
CDLX (CARDLYTICS INC) is a Information Technology company. 6 other funds we track also report a position in CDLX — the largest reported positions include CAS Investment Partners, LLC (US$2.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CDLX
- CAS Investment Partners, LLC 470.99K sh · $2.11M · Q2 2026
More on PenderFund Capital Management Ltd.
FAQ
How long has PenderFund Capital Management Ltd. held CDLX?
PenderFund Capital Management Ltd. has disclosed CDLX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is PenderFund Capital Management Ltd.'s current position in CDLX?
As of Q2 2026, PenderFund Capital Management Ltd. holds 53.80M shares of CDLX (CARDLYTICS INC), valued at $15.52M, representing 2.58% of its reported portfolio and ranking #10.
Has PenderFund Capital Management Ltd. been buying or selling CDLX?
In the latest 13F filing (Q2 2026), PenderFund Capital Management Ltd. increased its position in CDLX. The position peaked in Q4 2025 at 47.71M shares.
Which other funds hold CDLX?
Other major institutional holders of CDLX include CAS Investment Partners, LLC, among 6 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.